Meeting NewsVideo

VIDEO: Genetic therapies are the future in AMD treatment

ATLANTA – Eric Sigler, MD, focused on choroidal retinal degenerations during the Retina Roundup here at SECO. “We found that it’s an exciting time, as many treatments will be effective in the future like lampalizumab and other genetic therapies to modify the risk and progression of macular degeneration,” he said.

Sigler is a board-certified ophthalmologist specializing in medical and surgical diseases of the retina and vitreous at Ophthalmic Consultants of Long Island.

ATLANTA – Eric Sigler, MD, focused on choroidal retinal degenerations during the Retina Roundup here at SECO. “We found that it’s an exciting time, as many treatments will be effective in the future like lampalizumab and other genetic therapies to modify the risk and progression of macular degeneration,” he said.

Sigler is a board-certified ophthalmologist specializing in medical and surgical diseases of the retina and vitreous at Ophthalmic Consultants of Long Island.

    See more from SECO